Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV-Reference-Cited by-同舟云学术

Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV

Published:2022 Issue:S1 Volume:50 Page:32-39
ISSN:1073-1105
Container-title:Journal of Law, Medicine & Ethics
language:en
Short-container-title:J. Law. Med. Ethics

Author:

Ballreich Jeromie,Levengood Timothy,Conti Rena M.

Abstract

AbstractAntiretroviral pre-exposure prophylaxis (PrEP) is protective against HIV. Low utilization rates amongst HIV vulnerable populations are due in part to the high cost of PrEP. Generic PrEP offers the potential to improve health at significantly reduced costs. In this study, we examine early utilization patterns and prices for generic PrEP. We discuss the opportunities and challenges for generic PrEP to improve health among HIV vulnerable populations.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,General Medicine,Issues, ethics and legal aspects

Reference37 articles.

1. Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016

2. Preexposure Prophylaxis for the Prevention of HIV Infection

3. 22. Conrad and Lutter, supra note 9.

4. 2. Centers for Disease Control and Prevention, “2019 National HIV Surveillance System Reports,” May 27, 2021, available at (last visited March 25, 2022); America’s HIV Epidemic Analysis Dashboard, “PrEP Coverage,” December 2020, available at (last visited March 25, 2022).

5. Cheaper Generic PrEP Now Available in the United States;Highleyman;POZ,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatiotemporal Analysis of HIV/AIDS Incidence in China From 2009 to 2019 and Its Association With Socioeconomic Factors: Geospatial Study;JMIR Public Health and Surveillance;2024-06-07

2. Evolving Challenges in the Implementation of China’s “Four Frees and One Care” Policy for HIV/AIDS;Risk Management and Healthcare Policy;2024-05

3. Trends in HIV preexposure prophylaxis utilization and spending among individuals with commercial insurance;AIDS;2024-02-29

4. Spatiotemporal Analysis of HIV/AIDS Incidence in China From 2009 to 2019 and Its Association With Socioeconomic Factors: Geospatial Study (Preprint);2024-01-10

5. Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis;Health Affairs;2024-01-01